MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
83 hedge funds and large institutions have $136M invested in Melinta Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
26% less capital invested
Capital invested by funds: $183M → $136M (-$47M)
73% less call options, than puts
Call options by funds: $256K | Put options by funds: $951K
Holders
83
Holding in Top 10
1
Calls
$256K
Puts
$951K
Top Buyers
| 1 | +$23.1M | |
| 2 | +$14.8M | |
| 3 | +$2.22M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.22M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.17M |
Top Sellers
| 1 | -$507K | |
| 2 | -$391K | |
| 3 | -$294K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$287K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$240K |